Metsera Raises $215m, Bringing 2024 Total To $505m For Obesity Trials
Series B Round Comes Seven Months After Launch
After emerging with $290m in April and announcing Phase I data for its lead asset in September, Metsera raised another $215m to fund clinical trials for three obesity drug candidates.
